Investor Presentaiton
Purpose: to get ahead of disease together
For health impact, shareholder returns and thriving people
Six priority areas of
responsible business
Access
Environment
Global health and
health security
Diversity, equity
and inclusion
Product governance
Ethical standards
To impact the health of >2.5 billion people over
the next 10 years
#1 position in the Access to Medicines Index for 8th
consecutive year and a leading approach in AMR¹
£100m investment to support health system strengthening in
lower income countries and £1bn investment in global health
R&D
Presented positive Phase Ila study results for a new first-in-
class candidate medicine for patients with tuberculosis
Launched Sustainable Procurement Programme for suppliers
to support climate and nature targets
GSK
1. Antimicrobial resistance
27
27View entire presentation